EVALUATING THE EPIDEMIOLOGICAL IMPACT OF INTRODUCTION OF PNEUMOCOCCAL CONJUGATE VACCINE AS PART OF THE NATIONAL IMMUNIZATION SCHEDULE OF KAZAKHSTAN

被引：0
|
作者：
Balabayev, T. [1 ]
Kostyuk, A. [2 ]
Almadiyeva, A. [3 ]
Sultanov, M. [3 ]
Absattarova, K. [3 ]
Almatova, V [3 ]
机构：
[1] Kazakhstan Assoc HTA EBM & Pharmacoecon Res KazSP, Astana, Kazakhstan
[2] Kazakhstan Assoc HTA EBM & Pharmacoecon Res KazSP, Alma Ata, Akm, Kazakhstan
[3] Kazakh Agcy Hlth Technol Assessment, Astana, Kazakhstan
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.1738
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRS34
引用
收藏
页码：S355 / S355
页数：1
相关论文
共 50 条
  • [1] Impact of the introduction of pneumococcal conjugate vaccine on immunization coverage
    Lin, ND
    Kleinman, K
    Ye, XJ
    France, E
    Wei, FF
    Mullooly, JP
    Santoli, JM
    Lieu, TA
    PEDIATRIC RESEARCH, 2004, 55 (04) : 317A - 317A
  • [2] Impact of the introduction of the pneumococcal conjugate vaccine in the Brazilian routine childhood national immunization program
    Moreira, Marta
    Cintra, Otavio
    Harriague, Julie
    Hausdorff, William P.
    Hoet, Bernard
    VACCINE, 2016, 34 (25) : 2766 - 2778
  • [3] Impact of the introduction of pneumococcal conjugate vaccine on immunization coverage among infants
    Lin N.D.
    Kleinman K.
    Chan K.A.
    Yu X.-J.
    France E.K.
    Xu S.
    Wei F.
    Mullooly J.
    Santoli J.
    Lieu T.A.
    DeStefano F.
    Chen R.T.
    Shay D.
    Rhodes P.H.
    Kolzcak M.
    Gee P.H.
    Davis R.L.
    Thompson W.
    Baggs J.
    Barry B.
    Bridges C.
    Campbell S.
    Casey C.
    Chen J.
    Denson C.
    Elswich D.
    Euler G.
    Gargiullo P.
    Harpaz R.
    Hibbs B.
    Jumaan A.
    King D.
    Kohl K.S.
    Kramarz P.
    Mootrey G.
    Moran J.
    Nuorti P.
    Pool V.
    Singleton J.
    Weintraub E.
    Weniger B.
    Wharton M.
    Xu F.
    Zhou W.
    Braun M.M.
    Wise R.P.
    Ball R.
    Burwen D.
    Davis D.
    Izurieta H.
    BMC Pediatrics, 5 (1)
  • [4] The immunogenicity and impact on nasopharyngeal carriage of fewer doses of conjugate pneumococcal vaccine immunization schedule
    Ota, Martin O.
    Akinsola, Adebayo
    Townend, John
    Antonio, Martin
    Enwere, Godwin
    Nsekpong, David
    Bojang, Abdoulie
    Saaka, Mark
    Burton, R. L.
    Zaman, Akram
    Goldblatt, David
    Adegbola, Richard A.
    VACCINE, 2011, 29 (16) : 2999 - 3007
  • [5] Typhoid Conjugate Vaccine: Is It Time for It To Be in the National Immunization Schedule?
    Nabaneeta Dash
    Winsley Rose
    Indian Pediatrics, 2020, 57 : 609 - 610
  • [6] Typhoid Conjugate Vaccine: Is It Time for It To Be in the National Immunization Schedule?
    Dash, Nabaneeta
    Rose, Winsley
    INDIAN PEDIATRICS, 2020, 57 (07) : 609 - 610
  • [7] Clinical and epidemiological impact of varicella infection in children prior to the introduction of the varicella vaccine in the national immunization schedule of Argentina
    Neyro, Silvina E.
    Ferolla, Fausto M.
    Molise, Claudia
    Stach, Patricia
    Romano, Pablo
    Marone, Silvia
    de Mena, Arturo
    Plat, Fabiola
    Voto, Carla
    Soto, Pedro
    Bustos, Laura
    Clavijo, Cecilia
    Murgo, Daniel
    Dozoretz, Daniel
    Fiorentino, Jorge
    Lopez, Eduardo L.
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2019, 117 (01): : 12 - 18
  • [8] The impact of pneumococcal conjugate vaccine on provider immunization practices
    Lee, KC
    Finkelstein, JA
    Miroshnik, I
    Rusinak, D
    Santoli, J
    Lett, SM
    Platt, R
    Lieu, TA
    PEDIATRIC RESEARCH, 2003, 53 (04) : 306A - 306A
  • [9] Pneumococcal meningitis before the introduction of 10-valent pneumococcal conjugate vaccine into the National Childhood Immunization Program in Poland
    Polkowska, Aleksandra
    Skoczynska, Anna
    Paradowska-Stankiewicz, Iwona
    Stefanoff, Pawel
    Hryniewicz, Waleria
    Kuch, Alicja
    Lyytikainen, Outi
    Nuorti, J. Pekka
    VACCINE, 2019, 37 (10) : 1365 - 1373
  • [10] Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe
    Rose, Markus
    Zielen, Stefan
    EXPERT REVIEW OF VACCINES, 2009, 8 (10) : 1351 - 1364
12345